Dennard v. Astellas Pharma Inc.

CourtDistrict Court, N.D. Illinois
DecidedSeptember 30, 2024
Docket1:22-cv-02836
StatusUnknown

This text of Dennard v. Astellas Pharma Inc. (Dennard v. Astellas Pharma Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dennard v. Astellas Pharma Inc., (N.D. Ill. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

NICKIE DENNARD, SHARI LEWAN, JESSICA VANDENBOSCH, STEPHEN SLEEM, DERECK JOHNSON, LINDA DAVAULT, DR. TERRELL REHMUS, JACQUELINE CLEGG, REGINA LANGLEY, and GERALD KREUTZER,

Plaintiffs, No. 22-cv-02836

v. Judge John F. Kness

ASTELLAS PHARMA US, INC., and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.,

Defendants.

MEMORANDUM OPINION AND ORDER This case centers around healthcare employees who refused to comply with their employer’s mandatory COVID-19 vaccination policy. The employees claimed their religious beliefs prohibited them from receiving the vaccination, but their requests for a religious exemption were rejected by Astellas, their employer. The employees were eventually terminated, and they bring two counts against Astellas in this case. Count I alleges that Astellas violated the Illinois Health Care Right of Conscience Act (the “HCRCA”), which protects individuals from receiving or performing health care services that violate their conscience. Astellas moves to dismiss Claim I, arguing that § 13.5 of the HCRCA, which exempts COVID-19 vaccination policies from its coverage, disposes of the claim. Plaintiffs argue in response that § 13.5 is unconstitutional. Count II alleges religious discrimination in violation of Title VII. Astellas moves to compel discovery in Count II.

On May 2, 2024, Plaintiffs Shari Lewan, Jessica Vandenbosch, Stephen Sleem, Dereck Johnson, Linda Davault, Dr. Terrell Rehmus, Jaqueline Clegg, Regina Langley, and Gerald Kreutzer (together, the “Settling Plaintiffs”) filed a joint stipulation of dismissal. (Dkt. 73.) That stipulation results, by the operation of Rule 41(a)(1) of the Federal Rules of Civil Procedure, in the dismissal of the case with prejudice as to the Settling Plaintiffs. See Nelson v. Napolitano, 657 F.3d 586, 587 (7th Cir. 2011). Because the pending motion to compel discovery applied only to the

Settling Plaintiffs, the motion to compel discovery (Dkt. 61) is dismissed as moot. For the reasons that follow, Astellas’s motion to dismiss is granted in part and entered and continued in part as to Plaintiff Nickie Dennard. As explained more fully below, § 13.5 of the HCRCA precludes Plaintiff Dennard’s claim. But Plaintiff’s constitutionality argument survives for now, pending, as discussed below, the filing and service of the constitutional question to the appropriate attorney general.

I. BACKGROUND Plaintiff Nickie Dennard, the sole remaining plaintiff in this case, filed this lawsuit against Defendants Astellas Pharma US, Inc. and Astellas Pharma Global Development, Inc. (collectively, “Defendants” or “Astellas”) alleging a violation of the Illinois Health Care Right of Conscience Act, 735 ILCS 70 (Count I) and a violation of Title VII, 42 U.S.C. § 2000e (Count II). (Dkt. 32.) Plaintiff is a pharmaceutical professional who was employed by Astellas for eleven years as an Executive Medical Specialties Representative. (Dkt. 32 ¶¶ 2, 7.) On October 5, 2021, Astellas announced that all U.S. employees were required to be

vaccinated as a condition of employment, despite previous assurances that COVID- 19 vaccinations would not be required for employees. (Id. ¶¶ 33–36, 41.) Astellas allowed employees to obtain a religious exemption from the vaccination requirement if they completed a “Religious Accommodation Request Form” and a “Religious Leader / Attestor Certification Form.” (Id. ¶ 48.) Upon receiving the forms, Astellas would “assess accommodation requests on a case-by-case basis” through an “interactive process.” (Id. ¶ 42; Dkt. 1-3 at 2.) Astellas would offer reasonable

accommodations “where it does not create an undue hardship,” but unvaccinated employees who were not granted an accommodation would be placed on unpaid leave and later terminated. (Dkt. 32 ¶ 42; Dkt. 1-3 at 2.) Plaintiff completed the required forms to request a religious exemption. (Dkt. 32 ¶ 49.) The foundation of this exemption request was Plaintiff’s sincerely held religious belief “rooted in the Scriptures.” (Id. ¶ 72.) Plaintiff believed that getting a

COVID-19 vaccine was “an affront to Scripture’s teaching that all life is sacred,” because all COVID-19 vaccines “were derived from, produced, manufactured by, tested on, developed with, or otherwise connected to aborted fetal cell lines.” (Id. ¶¶ 72, 73.) Astellas preemptively denied Plaintiff’s exemption request because “allowing an accommodation to the vaccination requirement in your circumstance would present an undue hardship to [Astellas] due to the public-facing nature of your role and continuing threat posed by the COVID-19 pandemic.” (Id. ¶¶ 49–50, 56.) Plaintiff was placed on unpaid leave and eventually terminated. (Id. ¶ 61.) Plaintiff filed this lawsuit to address Astellas’s alleged discrimination against

her. (Dkt. 32 ¶ 1.) Plaintiff brings two counts against Defendants. Count I alleges a violation of the HCRCA, which makes it unlawful for an employer to “discriminate against any person . . . because of such person’s conscientious refusal to . . . participate in any . . . particular form of health care services contrary to his or her conscience.” 745 ILCS 70/5. Defendants moved to dismiss Count I, arguing first that the HCRCA does not apply to Plaintiff, and then arguing that § 13.5 of the HCRCA precludes Plaintiff’s claim. (Dkt. 44.) Section 13.5 exempts an employer’s

COVID-19 prevention measures from the HCRCA. 745 ILCS 70/13.5. Count II alleges religious discrimination in violation of Title VII. Defendants did not move to dismiss Count II, but Defendants did not file an answer to Count II. But because it appears that the parties are proceeding with discovery in Count II in good faith, Defendants’ failure to answer Count II was likely an oversight. (See Dkts. 57; 68.) Defendants must therefore file an answer to Count II on or before October 21,

2024. II. STANDARD OF REVIEW A motion under Rule 12(b)(6) “challenges the sufficiency of the complaint to state a claim upon which relief may be granted.” Hallinan v. Fraternal Ord. of Police of Chi. Lodge No. 7, 570 F.3d 811, 820 (7th Cir. 2009). Each complaint “must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’ ” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007)). These allegations “must be enough to raise a right to relief above the speculative level.” Twombly, 550 U.S. at 555. Put another

way, the complaint must present a “short, plain, and plausible factual narrative that conveys a story that holds together.” Kaminski v. Elite Staffing, Inc., 23 F.4th 774, 777 (7th Cir. 2022) (cleaned up). In evaluating a motion to dismiss, the Court must accept as true the complaint’s factual allegations and draw reasonable inferences in the plaintiff’s favor. Iqbal, 556 U.S. at 678. But even though factual allegations are entitled to the assumption of truth, mere legal conclusions are not. Id. at 678–79. III. DISCUSSION

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Nelson v. Napolitano
657 F.3d 586 (Seventh Circuit, 2011)
Free v. Holy Cross Hospital
505 N.E.2d 1188 (Appellate Court of Illinois, 1985)
Joanne Kaminski v. Elite Staffing, Inc.
23 F.4th 774 (Seventh Circuit, 2022)
Lenz v. Advocate Health & Hospitals Corp.
2023 IL App (1st) 230740 (Appellate Court of Illinois, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Dennard v. Astellas Pharma Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/dennard-v-astellas-pharma-inc-ilnd-2024.